CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
CTT PHARMACEUTICAL HOLDINGS, INC.
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Sep 17, 2026
$0.06−0.00 (-0.17%)
Close on Oct 16, 2026
- Market cap
- $1.26M
- P/E (TTM)
- –
- Dividend yield
- –
Ctt Pharmaceutical statistics
Financials through Dec 31, 2014, price as of Oct 16, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Ctt Pharmaceutical | Industry median |
|---|---|---|
| Market Cap | $3.52M | $166.30M |
| Enterprise Value | $3.44M | $88.19M |
| PB Ratio | 2.36 | 2.03 |
| P/TBV Ratio | 2.36 | 2.29 |
Income (trailing twelve months)
| Measure | Ctt Pharmaceutical | Industry median |
|---|---|---|
| Operating Income | -$672.16K | -$21.40M |
| Net Income | -$672.16K | -$22.46M |
| EBITDA | -$672.16K | -$16.91M |
| EPS (Diluted) | -$0.00 | -$0.83 |
Returns
| Measure | Ctt Pharmaceutical | Industry median |
|---|---|---|
| Return on Equity (ROE) | -45.0% | -53.2% |
| Return on Assets (ROA) | -40.4% | -40.9% |
| Return on Invested Capital (ROIC) | -37.6% | -32.4% |
Balance sheet
| Measure | Ctt Pharmaceutical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $81.18K | $61.43M |
| Net Cash (Debt) | $81.18K | $15.35M |
| Net Cash Per Share | $0.00 | $0.66 |
| Equity (Book Value) | $1.49M | $49.09M |
| Book Value Per Share | $0.02 | $1.37 |
| Tangible Book Value | $1.49M | $23.52M |
Cash flow (trailing twelve months)
| Measure | Ctt Pharmaceutical | Industry median |
|---|---|---|
| Operating Cash Flow | -$72.25K | -$12.35M |
Efficiency
| Measure | Ctt Pharmaceutical | Industry median |
|---|---|---|
| Profits Per Employee | -$336.08K | -$703.34K |
| Employee Count | 2 | 74 |
Dividends and yields
| Measure | Ctt Pharmaceutical | Industry median |
|---|---|---|
| Earnings Yield | -19.1% | -23.3% |
Shares
| Measure | Ctt Pharmaceutical | Industry median |
|---|---|---|
| Shares Outstanding | 59,722,200 | 58,127,000 |
| Float | 50,297,700 | 49,136,700 |
| Shares Held by Insiders | 15.8% | 11.6% |
Scores
| Measure | Ctt Pharmaceutical | Industry median |
|---|---|---|
| Altman Z-Score | 10.39 | -0.22 |
Calculated by StockData from Ctt Pharmaceutical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.